ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oregon » Internal Medicine

Top Internal Medicine Prescribers in Oregon

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICHARD KIMANI M.D.

Internal Medicine

25,008

$1.27M

795
642 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $54

VUONG TRAN MD

Internal Medicine

21,813

$694K

585
515 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

18%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$32
Average prescription price

Avg: $54

STEVEN ATHAY M.D.

Internal Medicine

19,876

$880K

902
807 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $54

HSIANG-SEN YEH M.D.

Internal Medicine

19,056

$927K

767
608 are 65+

19%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $54

SEAN STADTLANDER MD

Internal Medicine

18,977

$850K

780
694 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $54

PAUL HUUN M.D.

Internal Medicine

18,524

$805K

711
630 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $54

GREGORY LACKIDES M.D.

Internal Medicine

18,272

$825K

782
641 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $54

MAGHA DISSANAYAKE MD

Internal Medicine

17,234

$968K

357
289 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

29%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $54

MICHAEL BOWER MD

Internal Medicine

17,116

$704K

927
774 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $54

EDWARD WOLF M.D.

Internal Medicine

16,678

$893K

866
810 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $54

RICHARD CRAFT MD

Internal Medicine

16,656

$918K

551
450 are 65+

21%
patients receiving schedule two controlled substances

Avg: 9%

18%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $54

PATRICK MCGOWAN MD

Internal Medicine

16,076

$909K

381
324 are 65+

25%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $54

MICHELLE JOHN M.D.

Internal Medicine

15,997

$657K

651
480 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $54

JOHN OPPENHEIMER MD

Internal Medicine

15,540

$763K

645
577 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $54

JASON PHILLIPS M.D.

Internal Medicine

15,030

$871K

548
422 are 65+

20%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $54

MICHAEL CARROLL MD

Internal Medicine

14,947

$765K

706
585 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $54

MICHAEL LAURIE M.D.

Internal Medicine

14,921

$818K

676
520 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $54

ANDREW KIM MD

Internal Medicine

14,836

$805K

624
487 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$54
Average prescription price

Avg: $54

ELIZABETH NEELEY M.D.

Internal Medicine

14,439

$700K

713
553 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$48
Average prescription price

Avg: $54

CELSO GANGAN M.D

Internal Medicine

14,410

$731K

573
513 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $54

JAMIE RICH M.D.

Internal Medicine

14,403

$1M

486
358 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

18%
patients receiving schedule three controlled substances

Avg: 13%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $54

ROBERT BERGSTROM MD

Internal Medicine

14,401

$637K

581
486 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

20%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $54

KURT BRICKNER DO

Internal Medicine

14,227

$1.02M

563
500 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$72
Average prescription price

Avg: $54

KIRK JACOBSON M.D.

Internal Medicine

14,219

$1.06M

736
648 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 13%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$75
Average prescription price

Avg: $54

HAROLD PALMER MD

Internal Medicine

14,160

$824K

617
552 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

18%
patients receiving schedule three controlled substances

Avg: 13%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $54

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank